Torvaianica, Italy

Carsten Schultz-Fademrecht

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Janssen Pharmaceutica Nv. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carsten Schultz-Fademrecht. Retrieved from https://idiyas.com/inventor/carsten-schultz-fademrecht-kvuk2c45

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Jorvaianica, IL (2013)
  • Torvaianica, IT (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Carsten Schultz-Fademrecht: Innovator in Quinazoline Derivatives

Introduction

Carsten Schultz-Fademrecht is a notable inventor based in Torvaianica, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his work on Quinazoline derivatives. With a total of two patents to his name, Schultz-Fademrecht continues to push the boundaries of innovation in his industry.

Latest Patents

His latest patents focus on Quinazoline derivatives, which are compounds that have shown potential in various therapeutic applications. The present invention concerns the compounds of a specific formula, highlighting the innovative nature of his work in this area.

Career Highlights

Carsten Schultz-Fademrecht is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical sector. His role at Janssen has allowed him to collaborate with other experts and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Eddy Jean Edgard Freyne and Timothy Pietro Suren Perera. Their collaborative efforts have further enhanced the innovative projects they are involved in.

Conclusion

Carsten Schultz-Fademrecht exemplifies the spirit of innovation in the pharmaceutical industry through his work on Quinazoline derivatives. His contributions and collaborations continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…